Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 1/20 | 0.70 |
| ▸ | NPY2R | P49146 | 1/20 | 0.70 |
| ▸ | NPY4R | P50391 | 1/20 | 0.70 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.70 |
| ▸ | GLP1R | P43220 | 12/20 | 0.69 |
| ▸ | GCGR | P47871 | 3/20 | 0.67 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.66 |
| ▸ | CALCR | P30988 | 2/20 | 0.65 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.65 |
| ▸ | CCKBR | P32239 | 4/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29429584 | 0.94 | NPY1R (0.73) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30213352 | 0.93 | GLP1R (0.73) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30403451 | 0.93 | GLP1R (0.73) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30658403 | 0.93 | CXCR4 (0.71) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30607286 | 0.93 | IL23R (0.67) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL29429573 | 0.93 | GLP1R (0.71) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30578730 | 0.92 | NPY1R (0.70) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30658254 | 0.92 | KEAP1 (0.72) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30932069 | 0.92 | GLP1R (0.74) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30658327 | 0.92 | GLP1R (0.69) | NPY1RNPY2RNPY4RNPY5RGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753627-B2 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-09-12 | — | — | US | disclosed |